Field Katharyn 4
4 · Virpax Pharmaceuticals, Inc. · Filed Jul 10, 2024
Insider Transaction Report
Form 4
Field Katharyn
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-05+2,500→ 2,500 totalExercise: $0.58Exp: 2034-07-04→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The option vests in full on the twelve-month anniversary of the grant date.